･ intracranial arterial dissection In this study, 632 patients from 172 neurosurgical institutes were enrolled. They were divided into 3 groups: (1) hemorrhage group consisting of 193 (30.5%) patients with subarachnoid hemorrhage; (2) ischemia group consisting of 209 (33.1%) patients with brain infarction or transient ischemic attack;
orrhage group. In contrast, conservative treatment was administered to a majority of the patients in the ischemia and headache groups. Antithrombotic therapy was administered to 79% of the patients in the ischemia group, and to 17% in the headache group. (5) Follow-up periods: The median follow-up period was 5, 10, and 12 months in the hemorrhage, ischemia, and headache group, respectively. (6)
Mid-term outcomes: Good outcomes were observed in 57% of the patients in the hemorrhage group; however, 26% of the patients in this group died. Furthermore, good outcomes were observed in 85%
and 98% of the patients in the ischemia and headache group, respectively; the mortality rate in these 2 groups was rather low.
These data were compared to those of the previous studies, such as the nationwide study in 1995-96
by Yamaura et al. The number of patients in the headache group was higher in this than in the previous studies. The number of patients with hemorrhage who received surgical treatment, especially endovascular surgery, was higher in this than in the previous studies. Furthermore, the number of patients in the ischemia and headache groups who received antithrombotic therapy was higher in this than in the previous studies. However, the clinical features, radiographic findings, and outcomes did not differ significantly between the present study and the previous studies. Antiplatelet & Anticoagulant meaning that both drugs were prescribed simultaneously or at different stages. Parenthesis indicates percentage Table 6 Outcome at the final contact after onset in the three groups 
群や虚血群が高率であった （F，G） ．
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